[HTML][HTML] European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in …

J van Prehn, E Reigadas, EH Vogelzang… - Clinical Microbiology …, 2021 - Elsevier
Abstract Scope In 2009, the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) published the first treatment guidance document for Clostridioides …

[HTML][HTML] Prognostic factors for severe and recurrent Clostridioides difficile infection: a systematic review

TM van Rossen, RE Ooijevaar… - Clinical Microbiology …, 2022 - Elsevier
Objectives Clostridioides difficile infection (CDI), its subsequent recurrences (rCDIs), and
severe CDI (sCDI) provide a significant burden for both patients and the healthcare system …

[PDF][PDF] TFPI is a colonic crypt receptor for TcdB from hypervirulent clade 2 C. difficile

J Luo, Q Yang, X Zhang, Y Zhang, L Wan, X Zhan… - Cell, 2022 - cell.com
The emergence of hypervirulent clade 2 Clostridioides difficile is associated with severe
symptoms and accounts for> 20% of global infections. TcdB is a dominant virulence factor of …

Incidence and outcomes associated with clostridioides difficile infection in solid organ transplant recipients

SM Hosseini-Moghaddam, B Luo, SE Bota… - JAMA Network …, 2021 - jamanetwork.com
Importance Little is known about the incidence and outcomes ofClostridioides
difficileinfection (CDI) in solid organ transplant (SOT) recipients. Objective To estimate the …

Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction …

O Ballo, EM Kreisel, F Eladly, U Brunnberg… - Annals of …, 2020 - Springer
Patients with acute myeloid leukemia (AML) are often exposed to broad-spectrum antibiotics
and thus at high risk of Clostridioides difficile infections (CDI). As bacterial infections are a …

Are Clostridium difficile toxins nephrotoxic?

N Cimolai - Medical Hypotheses, 2019 - Elsevier
Clostridium difficile-associated disease (CDAD) occurs along a spectrum from simple
uncomplicated enteritis to a multi-system disease which may include nephropathy …

The rise of Clostridioides difficile infections and fall of associated mortality in hospitalized advanced cirrhotics

R Rosenblatt, A Mehta, S Cohen‐Mekelburg… - Liver …, 2019 - Wiley Online Library
Abstract Background & Aims Cirrhotics are at increased risk of Clostridioides difficile
infection (CDI) and its associated high morbidity and mortality. However, the impact of CDI in …

Clostridium difficile infection in the emergency department

SK Garg, I Obaitan, S Sarvepalli… - Journal of clinical …, 2020 - journals.lww.com
Methods: Using Nationwide Emergency Department Sample for 2006 through 2014, we
identified all patients with the primary diagnosis of CDI (using diagnostic codes). We …

[HTML][HTML] Outcomes among inpatients with cirrhosis and Clostridioides difficile infection in the modern era: results from an analysis of the National Inpatient Sample

S Iriana, S Sharma, S McDonough… - Annals of …, 2021 - ncbi.nlm.nih.gov
Background Patients with cirrhosis are at increased risk of Clostridioides difficile infection
(CDI). We analyzed outcomes and healthcare utilization in hospitalized cirrhotic patients …

Predictors of mortality in patients with Clostridium difficile infection

YM Chu, CL Lee, HY Chen… - Advances in Digestive …, 2020 - Wiley Online Library
Clostridium difficile infection (CDI) is one of the most common health‐care‐associated
infections and has become a crucial cause of morbidity and mortality in older patients, but …